News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,357 Results
Type
Article (65471)
Company Profile (333)
Press Release (692553)
Section
Business (215868)
Career Advice (2408)
Deals (37190)
Drug Delivery (108)
Drug Development (85664)
Employer Resources (180)
FDA (16835)
Job Trends (15880)
News (365478)
Policy (34880)
Tag
2024 BioCapital Digital (15)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (11)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (7)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2917)
Academic (1)
Accelerated approval (2)
Adcomms (23)
Allergies (85)
Alliances (53560)
ALS (89)
Alzheimer's disease (1424)
Antibody-drug conjugate (ADC) (121)
Approvals (16828)
Artificial intelligence (252)
Autoimmune disease (15)
Automation (14)
Bankruptcy (376)
Best Places to Work (12020)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (210)
Bladder cancer (56)
Brain cancer (28)
Breast cancer (254)
Cancer (2039)
Cardiovascular disease (161)
Career advice (2009)
Career pathing (32)
CAR-T (148)
Cell therapy (417)
Cervical cancer (18)
Clinical research (68809)
Collaboration (807)
Compensation (451)
Complete response letters (25)
COVID-19 (2781)
CRISPR (41)
C-suite (216)
Cystic fibrosis (104)
Data (1922)
Decentralized trials (2)
Denatured (29)
Depression (42)
Diabetes (250)
Diagnostics (6586)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (115)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (88)
Earnings (88555)
Editorial (38)
Employer branding (22)
Employer resources (155)
Events (117744)
Executive appointments (653)
FDA (17958)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (721)
Gene editing (104)
Generative AI (22)
Gene therapy (297)
GLP-1 (742)
Government (4667)
Grass and pollen (4)
Guidances (48)
Healthcare (19671)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2916)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (85)
Interviews (409)
IPO (16935)
IRA (47)
Job creations (4304)
Job search strategy (1711)
Kidney cancer (9)
Labor market (34)
Layoffs (489)
Leadership (18)
Legal (8581)
Liver cancer (73)
Lung cancer (296)
Lymphoma (132)
Machine learning (2)
Management (62)
Manufacturing (282)
MASH (62)
Medical device (13660)
Medtech (13665)
Mergers & acquisitions (20712)
Metabolic disorders (656)
Multiple sclerosis (71)
NASH (17)
Neurodegenerative disease (86)
Neuropsychiatric disorders (26)
Neuroscience (1920)
NextGen: Class of 2025 (6892)
Non-profit (4854)
Northern California (2411)
Now hiring (37)
Obesity (358)
Opinion (237)
Ovarian cancer (72)
Pain (87)
Pancreatic cancer (77)
Parkinson's disease (135)
Partnered (19)
Patents (208)
Patient recruitment (94)
Peanut (50)
People (60806)
Pharmaceutical (94)
Pharmacy benefit managers (19)
Phase I (21345)
Phase II (30145)
Phase III (22549)
Pipeline (979)
Podcasts (80)
Policy (120)
Postmarket research (3005)
Preclinical (9550)
Press Release (71)
Prostate cancer (94)
Psychedelics (34)
Radiopharmaceuticals (258)
Rare diseases (376)
Real estate (6645)
Recruiting (68)
Regulatory (23637)
Reports (46)
Research institute (2627)
Resumes & cover letters (396)
Rett syndrome (3)
RNA editing (2)
RSV (40)
Schizophrenia (71)
Series A (126)
Series B (79)
Service/supplier (18)
Sickle cell disease (53)
Southern California (2088)
Special edition (16)
Spinal muscular atrophy (157)
Sponsored (30)
Startups (3893)
State (2)
Stomach cancer (13)
Supply chain (62)
The Weekly (48)
United States (21396)
Vaccines (714)
Venture capitalists (37)
Webinars (12)
Weight loss (250)
Women's health (34)
Worklife (15)
Date
Today (21)
Last 7 days (574)
Last 30 days (2612)
Last 365 days (34635)
2025 (7903)
2024 (36444)
2023 (41378)
2022 (52681)
2021 (57267)
2020 (55953)
2019 (48864)
2018 (36954)
2017 (34399)
2016 (34514)
2015 (41017)
2014 (35078)
2013 (31273)
2012 (32780)
2011 (33162)
2010 (31793)
Location
Africa (923)
Alabama (51)
Alaska (7)
Arizona (243)
Arkansas (14)
Asia (43519)
Australia (7432)
California (5533)
Canada (1876)
China (484)
Colorado (249)
Connecticut (262)
Delaware (129)
Europe (96000)
Florida (817)
Georgia (195)
Idaho (58)
Illinois (521)
India (24)
Indiana (297)
Iowa (9)
Japan (142)
Kansas (103)
Kentucky (24)
Louisiana (7)
Maine (60)
Maryland (846)
Massachusetts (4208)
Michigan (210)
Minnesota (378)
Mississippi (2)
Missouri (76)
Montana (30)
Nebraska (25)
Nevada (57)
New Hampshire (64)
New Jersey (1575)
New Mexico (31)
New York (1593)
North Carolina (971)
North Dakota (8)
Northern California (2411)
Ohio (195)
Oklahoma (14)
Oregon (38)
Pennsylvania (1253)
Puerto Rico (9)
Rhode Island (26)
South America (1291)
South Carolina (19)
South Dakota (1)
Southern California (2088)
Tennessee (94)
Texas (832)
Utah (169)
Virginia (139)
Washington D.C. (61)
Washington State (521)
West Virginia (3)
Wisconsin (52)
758,357 Results for "kyowa kirin pharmaceutical research inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Amgen, Kyowa Kirin’s Rocatinlimab Picks Up Steam With Late-Stage Atopic Dermatitis Win
In September 2024, a readout from a separate trial of rocatinlimab elicited mixed reactions from analysts, who found the antibody’s efficacy in that study to be underwhelming.
March 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025
February 26, 2025
·
4 min read
Business
Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company based in Japan, announced that its board of directors has approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, North Carolina.
June 10, 2024
·
4 min read
Press Releases
AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
March 10, 2025
·
16 min read
Pharm Country
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that data from the pre-clinical pharmacokinetics & efficacy study comparing ocular tissue distribution after ocular instillation of tivozanib eye drops will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held in Seattle, Washington from May 5-9, 2024.
May 8, 2024
·
4 min read
Press Releases
Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies
December 9, 2024
·
2 min read
Press Releases
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
February 5, 2025
·
14 min read
Pharm Country
Kyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that pre-clinical data of tivozanib (KHK-4951), an investigational product, assessing the ocular pharmacokinetics of a novel tivozanib eye drop for neovascular age-related macular degeneration (nAMD), will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held in Seattle, Washington from May 5-9, 2024.
April 2, 2024
·
3 min read
Press Releases
Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe
January 30, 2025
·
7 min read
Pharm Country
Kyowa Kirin to Present New Research on X-linked Hypophosphatemia (XLH) at ASBMR Annual Meeting
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company based in Japan, will share new research that advances understanding about the real-world experiences and clinical characteristics of children, adolescents, and adults living with X-linked hypophosphatemia (XLH), a rare genetic metabolic bone disease.
October 12, 2023
·
7 min read
1 of 75,836
Next
